Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Paul G. Richardson(Harvard University), Irene M. Ghobrial(Dana-Farber Cancer Institute), Andrea A. Zeytoonjian(Harvard University), Hamza Hashmi(Medical University of South Carolina), Kelly Masone(Harvard University), Abdullah Khan(Dana-Farber Cancer Institute), Kelly Godby(University of Alabama at Birmingham), Mounzer Agha(Dana-Farber Cancer Institute), Carter P. Milner(University of Mississippi Medical Center), Sagar Lonial(Emory University), Adam D. Cohen(Penn Center for AIDS Research), Astrid C. Andreescu(Eastern Maine Medical Center), Sundar Jagannath(Mount Sinai Hospital), Erica Campagnaro(University of Michigan), Teresa Gentile(SUNY Upstate Medical University), Cristina Gasparetto(Dana-Farber Cancer Institute), Jeffrey A. Zonder(The Barbara Ann Karmanos Cancer Institute), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Larry D. Anderson(Dana-Farber Cancer Institute), Nitya Nathwani(City of Hope), Mehmet Samur(Dana-Farber Cancer Institute), Eva Medvedova(Oregon Health & Science University), Jacob P. Laubach(Harvard University), Robert F. Cornell(Dana-Farber Cancer Institute), Pallawi Torka(Roswell Park Comprehensive Cancer Center), Krisstina Gowin(University of Arizona), Noopur Raje(Massachusetts General Hospital), Omar Nadeem(Harvard University), Andrew J. Yee(Harvard University), Hani Hassoun(Memorial Sloan Kettering Cancer Center), Mariateresa Fulciniti(Dana-Farber Cancer Institute), Philip L. McCarthy(Roswell Park Comprehensive Cancer Center), Susanna Jacobus(Harvard University), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Kyle Hebert(Harvard University), Peter M. Voorhees(Levine Cancer Institute), Jonathan L. Kaufman(Emory University), Edward N. Libby(University of Washington), Michaela Liedtke(Cancer Institute (WIA)), Amy Foley(National Marrow Donor Program), Marcelo C. Pasquini(Cleveland Clinic), Michelle E. Maglio(Harvard University), Melissa Alsina(Moffitt Cancer Center), Claudia E. Paba‐Prada(Harvard University), Emma C. Scott(Oregon Health & Science University), Rammurti T. Kamble(Baylor College of Medicine), Robert Schlossman(University of Leeds), Edie Weller(Boston Children's Hospital), David D. Hurd(Duke University), Thomas H. Openshaw(Cape Cod Hospital)
Cited by 457
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k